5 hrs ago
UPDATE 2-Merck Q2 profit tops estimates on strong consumer sales
Merck & Co Inc reported better-than-expected quarterly results on Tuesday, with sales of consumer products and medicines for arthritis and HIV helping to offset the impact of generic competition on other drug sales.
Mon Jul 28, 2014
C'mon, Yah Cowardly Lion: Courage to be the Change
When Bayer, a $7 billion multinational pharmaceutical company, acquired a smaller $300 million diagnostic company, CEO Rolf Classon chose to call it a "merger."
Ken Fisher's Top Increaes of the Second Quarter
CEO and CIO of Fisher Investments and regular Forbes contributor, Ken Fisher , had a pretty busy second quarter.
Fri Jul 25, 2014
Bee battle seeks hearts and minds
Adversaries aren't waiting for conclusive science on what's killing the honeybee.
Wed Jul 23, 2014
Xarelto Lawsuits Start To Be Filed In The US Due To "Irreversible Bleeds"
Germany-based Bayer AG is facing its first lawsuits in the United States over Xarelto, which is among the company's top-selling medications.
Tue Jul 15, 2014
Malini Moorthy Joins Bayer Corporation As U.S. Head Of Litigation
Ms. Moorthy brings extensive litigation experience and unparalleled knowledge of the legal issues facing the health care industry to her new role.
Mon Jul 14, 2014
Bayer, ArcelorMittal and ThyssenKrupp Sue EU Over Probe
Bayer AG , ArcelorMittal SA and ThyssenKrupp AG are among 50 companies suing European Union regulators over a probe into billions of euros of German energy subsidies they may be forced to pay back.
Fri Jul 11, 2014
Resource Investing News
Aston Bay Holdings Modifies MOU Condition Precedent, Amends Flow-Through Portion of Private Placement
Aston Bay Holdings Ltd. has, further to previous press releases, modified a condition precedent contained in its memorandum of understanding with a 100 percent owned subsidiary of Antofagasta plc, which was described in its June 18, 2014 release.
Mon Jul 07, 2014
Compugen shares rise on news of positive cancer collaboration with Bayer
The company said the milestone relates to the first of two checkpoint protein candidates.
Nexavar (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
Nexavar significantly extended progression-free survival in patients with RAI-refractory differentiated thyroid cancer compared to placebo in the Phase III DECISION trial /CNW/ - Bayer Inc. is pleased to announce the Health Canada approval of Nexavar for the treatment of patients with locally advanced or metastatic, progressive, differentiated ... (more)
Fri Jul 04, 2014
Zacks Reiterates "Neutral" Rating for Bayer AG
's stock had its "neutral" rating reiterated by Zacks in a report issued on Friday.
China approves Bayer deal to buy Dihon, other deals
The Chinese Ministry of Commerce's anti-monopoly bureau has approved German drugmaker Bayer AG's deal for traditional Chinese medicine drugmaker Dihon Pharmaceutical Group Co, in a raft of deals approved on Friday.
Mon Jun 30, 2014
Bayer CropScience building new greenhouse in RTP
Bayer CropScience, a maker of crop pesticides and genetic traits to improve soybean, corn and other crop seeds, is building a new, $29.6 million greenhouse at its Research Triangle Park campus.